These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 19236120

  • 1. Drug-versus-drug adverse event rate comparisons: a pilot study based on data from the US FDA Adverse Event Reporting System.
    Hochberg AM, Pearson RK, O'Hara DJ, Reisinger SJ.
    Drug Saf; 2009; 32(2):137-46. PubMed ID: 19236120
    [Abstract] [Full Text] [Related]

  • 2. An experimental investigation of masking in the US FDA adverse event reporting system database.
    Wang HW, Hochberg AM, Pearson RK, Hauben M.
    Drug Saf; 2010 Dec 01; 33(12):1117-33. PubMed ID: 21077702
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. AERS spider: an online interactive tool to mine statistical associations in Adverse Event Reporting System.
    Grigoriev I, zu Castell W, Tsvetkov P, Antonov AV.
    Pharmacoepidemiol Drug Saf; 2014 Aug 01; 23(8):795-801. PubMed ID: 24677538
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. How safe are recently FDA-approved antimicrobials? A review of the FDA adverse event reporting system database.
    Khadem TM, van Manen RP, Brown J.
    Pharmacotherapy; 2014 Dec 01; 34(12):1324-9. PubMed ID: 25421400
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Hypersensitivity reactions to anticancer agents: data mining of the public version of the FDA adverse event reporting system, AERS.
    Kadoyama K, Kuwahara A, Yamamori M, Brown JB, Sakaeda T, Okuno Y.
    J Exp Clin Cancer Res; 2011 Oct 05; 30(1):93. PubMed ID: 21970649
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Platinum agent-induced hypersensitivity reactions: data mining of the public version of the FDA adverse event reporting system, AERS.
    Sakaeda T, Kadoyama K, Yabuuchi H, Niijima S, Seki K, Shiraishi Y, Okuno Y.
    Int J Med Sci; 2011 Oct 05; 8(4):332-8. PubMed ID: 21611115
    [Abstract] [Full Text] [Related]

  • 15. Safety of lovastatin/extended release niacin compared with lovastatin alone, atorvastatin alone, pravastatin alone, and simvastatin alone (from the United States Food and Drug Administration adverse event reporting system).
    Alsheikh-Ali AA, Karas RH.
    Am J Cardiol; 2007 Feb 01; 99(3):379-81. PubMed ID: 17261402
    [Abstract] [Full Text] [Related]

  • 16. Standardizing drug adverse event reporting data.
    Wang L, Jiang G, Li D, Liu H.
    Stud Health Technol Inform; 2013 Feb 01; 192():1101. PubMed ID: 23920875
    [Abstract] [Full Text] [Related]

  • 17. Antimicrobials and the risk of torsades de pointes: the contribution from data mining of the US FDA Adverse Event Reporting System.
    Poluzzi E, Raschi E, Motola D, Moretti U, De Ponti F.
    Drug Saf; 2010 Apr 01; 33(4):303-14. PubMed ID: 20297862
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.